Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01358

Related search